drrc ... Statins ,
must be by now one of the most studied drugs in history.
I think the evidence clearly shows ,that those "at risk " and diabetics are at risk of CV events ...the benefits far out weigh the risks.
I suspect that since your friend's LDL is at 125 , her Endo may prescribe a very low dose generic Statin to begin with ...see how she tolerates that and then a follow up lipid panel in 3 mths .
After 3 mths , if she is handling the Statin fine and her LDL is above 70 , he may suggest she up the Statin dose to get her LDL close to or under 70.
Either way ...I strongly suggest she at least try a low dose Statin for 3 mths and see how she does and its effect on her lipid profile especially her LDL levels. .
OT ..is she aware of DexCom for Diabetes management.
They have inked a deal with Google Life sciences to develop new /smaller glucose sensors.
FDA has also just approved Dexcom's new G5 mobile continuous glucose monitoring system for use with Iphones
I was wondering if she ( or anyone else reading this ) knew of this system
Kiwi